Sub-Saharan Africa (IDA & IBRD countries) vs Tajikistan: Immunization, Hib3
Immunization, Hib3 over time
- Sub-Saharan Africa (IDA & IBRD countries)
- Tajikistan
How they compare
Tajikistan currently reports 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries), a difference of 23.0%.
That makes Tajikistan's figure about 1.3 times Sub-Saharan Africa (IDA & IBRD countries)'s.
Across all 17 years both countries report, Tajikistan has been ahead every year.
Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd and Tajikistan ranks 29th of 43 groups.
Tajikistan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Sub-Saharan Africa (IDA & IBRD countries) | Tajikistan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 47.3% | 69.5% | 22.2% | Tajikistan |
| 2010s | 68.4% | 95.9% | 27.5% | Tajikistan |
| 2020s | 73.4% | 96.8% | 23.4% | Tajikistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Sub-Saharan Africa (IDA & IBRD countries) or Tajikistan?
- Tajikistan, at 97.0% against 74.0% in Sub-Saharan Africa (IDA & IBRD countries) as of 2024.
- What is the difference in immunization, hib3 between Sub-Saharan Africa (IDA & IBRD countries) and Tajikistan?
- 23.0%, with Tajikistan ahead.
- How many years of comparable data are there for Sub-Saharan Africa (IDA & IBRD countries) and Tajikistan?
- 17 years are reported by both, from 2008 to 2024.
- How do Sub-Saharan Africa (IDA & IBRD countries) and Tajikistan rank globally for immunization, hib3?
- Sub-Saharan Africa (IDA & IBRD countries) ranks 32nd and Tajikistan ranks 29th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.